M Miura

Summary

Affiliation: Brookhaven National Laboratory
Country: USA

Publications

  1. ncbi Enhancement of the radiation response of EMT-6 tumours by a copper octabromotetracarboranylphenylporphyrin
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Br J Radiol 85:443-50. 2012
  2. ncbi Biodistribution of copper carboranyltetraphenylporphyrins in rodents bearing an isogeneic or human neoplasm
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973 5000, USA
    J Neurooncol 52:111-7. 2001
  3. ncbi Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin
    M Miura
    Medical Department, Building 490, Brookhaven National Laboratory, Upton, NY 11973-5000, USA
    Radiat Res 155:603-10. 2001
  4. ncbi Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
    Br J Radiol 77:573-80. 2004
  5. ncbi Porphyrin-mediated boron neutron capture therapy: a preclinical evaluation of the response of the oral mucosa
    G M Morris
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA
    Radiat Res 163:72-8. 2005
  6. ncbi Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973-5000, USA
    Br J Radiol 79:71-5. 2006
  7. ncbi Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy
    M W Renner
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973-5000, USA
    Anticancer Agents Med Chem 6:145-57. 2006

Detail Information

Publications7

  1. ncbi Enhancement of the radiation response of EMT-6 tumours by a copper octabromotetracarboranylphenylporphyrin
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA
    Br J Radiol 85:443-50. 2012
    ..Using the 9% CRM formulation of CuTCPBr, doses of 100, 210 or 400 mg kg(-1) of body weight were used in combination with single doses of 25-35 Gy 100 kVp X-rays...
  2. ncbi Biodistribution of copper carboranyltetraphenylporphyrins in rodents bearing an isogeneic or human neoplasm
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973 5000, USA
    J Neurooncol 52:111-7. 2001
    ....
  3. ncbi Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin
    M Miura
    Medical Department, Building 490, Brookhaven National Laboratory, Upton, NY 11973-5000, USA
    Radiat Res 155:603-10. 2001
    ..Equivalent long-term tumor control by a single exposure to 42 Gy X rays was achieved, but with greater damage to the irradiated leg...
  4. ncbi Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973-5000, USA
    Br J Radiol 77:573-80. 2004
    ..Although either CuTCPH or CuTCPBr can be labelled with (64)Cu for imaging by positron emission tomography (PET), CuTCPBr can also be labelled by (76)Br, another PET-imageable nuclide...
  5. ncbi Porphyrin-mediated boron neutron capture therapy: a preclinical evaluation of the response of the oral mucosa
    G M Morris
    Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA
    Radiat Res 163:72-8. 2005
    ....
  6. ncbi Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams
    M Miura
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973-5000, USA
    Br J Radiol 79:71-5. 2006
    ....
  7. ncbi Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy
    M W Renner
    Medical Department, Brookhaven National Laboratory, Upton, NY 11973-5000, USA
    Anticancer Agents Med Chem 6:145-57. 2006
    ..New delivery modalities have also greatly improved the targeting potential of compounds previously deemed unsuitable for applications in BNCT...